National Toxicology Program (NTP); Liaison and Scientific Review Office; Meeting of the NTP Board of Scientific Counselors Technical Reports Review Subcommittee, 45404-45406 [05-15539]

Download as PDF 45404 Federal Register / Vol. 70, No. 150 / Friday, August 5, 2005 / Notices Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room F1/F2, Bethesda, MD 20892. Closed: September 15, 2005, 8 a.m. to 9:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room F1/F2, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD., Director, Division of Extramural Activities, National Institute of Diabetes and Digestive and Kidney Diseases. 6707 Democracy Blvd., Room 715, Bethesda, MD 20892, (301) 594– 8843, stanfieldb@extra.niddk.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. the statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. Information is also available on the Institute’s/Center’s home page: https:// www.niddk.nih.gov/fund/divisions/DEA/ Council/coundesc.htm., where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: July 29, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–15509 Filed 8–4–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., VerDate jul<14>2003 15:34 Aug 04, 2005 Jkt 205001 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Review of an Unsolicited P01 Application. Date: September 8, 2005. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Sujata Vijh, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 594– 0985, vjhs@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 1, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–15536 Filed 8–4–05; 8:45 am] BILLING CODE 4140–01–M dissemination of Study findings to the public. Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Time: 1:30 p.m. to 3 p.m. Agenda: For questions or to register for the meeting please call Circle Solutions at (703) 902–1339 or via e-mail at ncs@circlesolutions.com. Registration deadline is noon on August 31, 2005. Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Marion Balsam, MD, Executive Secretary, National Children’s Study Advisory Committee, 6100 Executive Boulevard, Bethesda, MD 20892, 301–594– 9174. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: August 1, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–15537 Filed 8–4–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP); Liaison and Scientific Review Office; Meeting of the NTP Board of Scientific Counselors Technical Reports Review Subcommittee National Institutes of Health AGENCY: National Institute of Child Health and Human Development; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Children’s Study Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Children’s Study Advisory Committee, Ethics Subcommittee. Date: September 7, 2005. Time: 1:30 p.m. to 3 p.m. Agenda: Discussions will focus on the development of preliminary recommendations regarding the PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). ACTION: Meeting announcement and request for comments. SUMMARY: Pursuant to Public Law 92– 463, notice is hereby given of a meeting of the NTP Board of Scientific Counselors Technical Reports Review Subcommittee (TRR Subcommittee). The primary agenda topic is the peer review of the findings and conclusions of ten draft NTP Technical Reports (TR) of rodent toxicology and carcinogenicity studies conducted by the NTP (see Preliminary Agenda below). TRR Subcommittee meeting is open to the public with time scheduled for oral public comment. The NTP also invites written comments on any draft technical report discussed at the meeting. The TRR Subcommittee deliberations on the draft technical reports will be reported to the NTP Board of Scientific Counselors (NTP Board) at a future date. E:\FR\FM\05AUN1.SGM 05AUN1 Federal Register / Vol. 70, No. 150 / Friday, August 5, 2005 / Notices The TRR Subcommittee meeting will be held on September 27–28, 2005. Written comments should be received by September 13, 2005, to enable review by the TRR Subcommittee and NIEHS/ NTP staff prior to the meeting. Individuals wishing to make oral public comments are asked to contact Dr. Barbara Shane (see FOR FURTHER INFORMATION CONTACT below) by September 13, 2005, and if possible, also to send a copy of the statement or talking points at that time. Persons needing special assistance, such as sign language interpretation, or other reasonable accommodation in order to attend, are asked to notify Dr. Shane at least 7 business days prior to the meeting (see FOR FURTHER INFORMATION CONTACT below). ADDRESSES: The TRR Subcommittee meeting will be held in the Rodbell Auditorium, Rall Building at the NIEHS, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. A copy of the preliminary agenda, committee roster, and any additional information, when available, will be posted on the NTP Web site (https://ntp.niehs.nih.gov/ select ‘‘Advisory Boards and Committees’’) and provided upon request from the NTP (see FOR FURTHER INFORMATION CONTACT below). FOR FURTHER INFORMATION CONTACT: Public comments and any other correspondence should be submitted to Dr. Barbara Shane, Executive Secretary for the NTP Board (NTP Liaison and Scientific Review Office, NIEHS, P.O. Box 12233, MD A3–01, Research Triangle Park, NC 27709; telephone: 919–541–4253, fax: 919–541–0295; or email: shane@niehs.nih.gov). SUPPLEMENTARY INFORMATION: DATES: Background The primary agenda topic is the peer review of the findings and conclusions of ten draft NTP Technical Reports (TR) of rodent toxicology and carcinogenicity studies conducted by the NTP (see Preliminary Agenda below). Five of the reports are on studies with conventional strains of rats and mice (TR 523, TR 534, TR 535, TR 537, TR 538); four reports are on studies performed in genetically modified models (GMM) including Tg.AC hemizygous and p53 haploinsufficient mice (GMM 5, GMM 6, GMM 10 and GMM 11), and one study is with Crl:SKH–1 hairless mice (TR 524). There will also be a presentation on background seizures in the F344/N rats used by the NTP. Attendance and Registration The meeting is scheduled for September 27–28, 2005, from 8:30 a.m. VerDate jul<14>2003 15:34 Aug 04, 2005 Jkt 205001 to adjournment and is open to the public with attendance limited only by the space available. Individuals who plan to attend are encouraged to register online at the NTP Web site by September 13, 2005, at https:// ntp.niehs.nih.gov/ select ‘‘Advisory Boards and Committees’’ to facilitate access to the NIEHS campus. Please note that a photo ID is required to access the NIEHS campus. The NTP is making plans to videocast the meeting through the Internet at https:// www.niehs.nih.gov/external/video.htm. Availability of Meeting Materials A copy of the preliminary agenda, committee roster, and any additional information, when available, will be posted on the NTP Web site (https:// ntp.niehs.nih.gov/ select ‘‘Advisory Boards and Committees’’) or may be requested in hardcopy from the NTP (see FOR FURTHER INFORMATION CONTACT above). Following the meeting, summary minutes will be prepared and made available on the NTP Web site. Request for Comments Public input at this meeting is invited and time is set aside for the presentation of public comments on any draft technical report. Each organization is allowed one time slot per agenda topic. At least 7 minutes will be allotted to each speaker, and if time permits, may be extended to 10 minutes. Registration for oral comments will also be available on-site, although time allowed for presentation by on-site registrants may be less than that for pre-registered speakers and will be determined by the number of persons who register at the meeting. Persons registering to make oral comments are asked, if possible, to send a copy of their statement to Dr. Shane (see FOR FURTHER INFORMATION CONTACT above) by September 13, 2005, to enable review by the TRR Subcommittee and NIEHS/NTP staff prior to the meeting. Written statements can supplement and may expand the oral presentation. If registering on-site and reading from written text, please bring 40 copies of the statement for distribution to the TRR Subcommittee and NIEHS/NTP staff and to supplement the record. Written comments received in response to this notice will be posted on the NTP website. Persons submitting written comments should include their name, affiliation, mailing address, phone, fax, e-mail, and sponsoring organization (if any) with the document. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 45405 Background Information on the NTP Board of Scientific Counselors The NTP Board is a technical advisory body comprised of scientists from the public and private sectors who provide primary scientific oversight to the overall program and its centers. Specifically, the NTP Board advises the NTP on matters of scientific program content, both present and future, and conducts periodic review of the program for the purposes of determining and advising on the scientific merit of its activities and their overall scientific quality. The TRR Subcommittee is at standing subcommittee of the NTP Board. NTP Board members are selected from recognized authorities knowledgeable in fields, such as toxicology, pharmacology, pathology, biochemistry, epidemiology, risk assessment, carcinogenesis, mutagenesis, molecular biology, behavioral toxicology and neurotoxicology, immunotoxicology, reproductive toxicology or teratology, and biostatistics. The NTP strives for equitable geographic distribution and minority and female representation on the NTP Board. Its members are invited to serve overlapping terms of up to four years. NTP Board meetings are held annually or biannually. Dated: July 28, 2005. Samuel H. Wilson, Deputy Director, National Institute of Environmental Health Sciences. Preliminary Agenda National Toxicology Program (NTP) Board of Scientific Counselors, Technical Reports Review Subcommittee Meeting, September 27– 28, 2005, Rodbell Auditorium, Rall Building, National Institute of Environmental Health Sciences, 111 TW Alexander Drive, Research Triangle Park, NC. NTP Technical Reports (TR) Scheduled for Review • TR 524: a- and β-Hydroxy acids (glycolic and salicylic acids, respectively) in combination with solar light (CAS Nos. 79–14–1 and 69–72–7, respectively) Æ Used in many cosmetic formulations for the treatment of skin conditions including acne, ichthyosis, actnic keratosis, warts and psoriasis • TR 537: Dibromoacetic acid) (CAS No. 631–64–1) Æ Water disinfection by-product • GMM 11: Dichloroacetic acid (CAS No. 79–43–6) Æ Water disinfection by-product E:\FR\FM\05AUN1.SGM 05AUN1 45406 Federal Register / Vol. 70, No. 150 / Friday, August 5, 2005 / Notices • GMM 5: Bromodichloromethane (CAS No 75–27–4) Æ Water disinfection by-product • GMM 6: Sodium bromate (CAS No. 7789–38–0) Æ Water disinfection by-product • TR 534: Divinylbenzene (high purity) (CAS No. 1321–74–0) Æ Used in production of vinyl polymers • TR 538: Methyl-isobutyl ketone (CAS No. 108–10–1) Æ Denaturant in rubbing alcohol, solvent for paints, used in industrial extraction processes, dry cleaning preparations and in synthetic reactions • TR 523: Diisopropylcarbodiimide (CAS No. 693–13–0) Æ Reagent for peptide synthesis, chemical intermediate and used in preparation of coatings • GMM 10: Diisopropylcarbodiimide (CAS No. 693–13–0) Æ Reagent for peptide synthesis, chemical intermediate and used in preparation of coatings • TR 535 4-Methylmidazole (822–36–6) Æ Used in manufacture of pharmaceuticals, dyes, agricultural chemicals and rubber Other Topics • Background Seizures Observed in F344/N Rats [FR Doc. 05–15539 Filed 8–4–05; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference call). Contact Person: Xiang-Ning Li, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217, MSC 7854, Bethesda, MD 20892, (301) 435– 1744, lixiang@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Mechanisms of Yersinia Virulence. Date: August 11, 2005. Time: 3:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Alexander D. Politis, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435– 1150, politisa@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–396, 93.837–93.844, 93.846– 93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 29, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–15510 Filed 8–4–05; 8:45 am] BILLING CODE 4140–01–M Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Overflow: Medical Imaging. Date: August 3, 2005. Time: 6 p.m. to 7 p.m. VerDate jul<14>2003 15:34 Aug 04, 2005 Jkt 205001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, August 11, 2005, 11 a.m. to August 11, 2005, 12:30 p.m. National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on July 13, 2005, 70 FR 40392–40393. The meeting will be held August 18, 2005, from 2 p.m. to 3:30 p.m. The meeting location remains the same. The meeting is closed to the public. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Dated: July 29, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–15511 Filed 8–4–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Institutes of Health Peer Review Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Institutes of Health Peer Review Advisory Committee. Date: September 26, 2005. Time: 8 a.m. to 5 p.m. Agenda: Provide technical and scientific advice to the Director, National Institutes of Health (NIH), the Deputy Director for Extramural Research, NIH and the Director, Center for Scientific Review (CSR), on matters relating broadly to review procedures and policies for the evaluation of scientific and technical merit of applications for grants and awards. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Karl Malik, Ph.D., Executive Secretary, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, MSC 7776, Bethesda, MD 20892, (301) 594–6806, malikk@csr.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 28, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–15512 Filed 8–4–05; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\05AUN1.SGM 05AUN1

Agencies

[Federal Register Volume 70, Number 150 (Friday, August 5, 2005)]
[Notices]
[Pages 45404-45406]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15539]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Toxicology Program (NTP); Liaison and Scientific Review 
Office; Meeting of the NTP Board of Scientific Counselors Technical 
Reports Review Subcommittee

AGENCY: National Institute of Environmental Health Sciences (NIEHS), 
National Institutes of Health (NIH).

ACTION: Meeting announcement and request for comments.

-----------------------------------------------------------------------

SUMMARY: Pursuant to Public Law 92-463, notice is hereby given of a 
meeting of the NTP Board of Scientific Counselors Technical Reports 
Review Subcommittee (TRR Subcommittee). The primary agenda topic is the 
peer review of the findings and conclusions of ten draft NTP Technical 
Reports (TR) of rodent toxicology and carcinogenicity studies conducted 
by the NTP (see Preliminary Agenda below). TRR Subcommittee meeting is 
open to the public with time scheduled for oral public comment. The NTP 
also invites written comments on any draft technical report discussed 
at the meeting. The TRR Subcommittee deliberations on the draft 
technical reports will be reported to the NTP Board of Scientific 
Counselors (NTP Board) at a future date.

[[Page 45405]]


DATES: The TRR Subcommittee meeting will be held on September 27-28, 
2005. Written comments should be received by September 13, 2005, to 
enable review by the TRR Subcommittee and NIEHS/NTP staff prior to the 
meeting. Individuals wishing to make oral public comments are asked to 
contact Dr. Barbara Shane (see FOR FURTHER INFORMATION CONTACT below) 
by September 13, 2005, and if possible, also to send a copy of the 
statement or talking points at that time. Persons needing special 
assistance, such as sign language interpretation, or other reasonable 
accommodation in order to attend, are asked to notify Dr. Shane at 
least 7 business days prior to the meeting (see FOR FURTHER INFORMATION 
CONTACT below).

ADDRESSES: The TRR Subcommittee meeting will be held in the Rodbell 
Auditorium, Rall Building at the NIEHS, 111 T. W. Alexander Drive, 
Research Triangle Park, NC 27709. A copy of the preliminary agenda, 
committee roster, and any additional information, when available, will 
be posted on the NTP Web site (https://ntp.niehs.nih.gov/ select 
``Advisory Boards and Committees'') and provided upon request from the 
NTP (see FOR FURTHER INFORMATION CONTACT below).

FOR FURTHER INFORMATION CONTACT: Public comments and any other 
correspondence should be submitted to Dr. Barbara Shane, Executive 
Secretary for the NTP Board (NTP Liaison and Scientific Review Office, 
NIEHS, P.O. Box 12233, MD A3-01, Research Triangle Park, NC 27709; 
telephone: 919-541-4253, fax: 919-541-0295; or e-mail: 
shane@niehs.nih.gov).

SUPPLEMENTARY INFORMATION:

Background

    The primary agenda topic is the peer review of the findings and 
conclusions of ten draft NTP Technical Reports (TR) of rodent 
toxicology and carcinogenicity studies conducted by the NTP (see 
Preliminary Agenda below). Five of the reports are on studies with 
conventional strains of rats and mice (TR 523, TR 534, TR 535, TR 537, 
TR 538); four reports are on studies performed in genetically modified 
models (GMM) including Tg.AC hemizygous and p53 haploinsufficient mice 
(GMM 5, GMM 6, GMM 10 and GMM 11), and one study is with Crl:SKH-1 
hairless mice (TR 524). There will also be a presentation on background 
seizures in the F344/N rats used by the NTP.

Attendance and Registration

    The meeting is scheduled for September 27-28, 2005, from 8:30 a.m. 
to adjournment and is open to the public with attendance limited only 
by the space available. Individuals who plan to attend are encouraged 
to register online at the NTP Web site by September 13, 2005, at http:/
/ntp.niehs.nih.gov/ select ``Advisory Boards and Committees'' to 
facilitate access to the NIEHS campus. Please note that a photo ID is 
required to access the NIEHS campus. The NTP is making plans to 
videocast the meeting through the Internet at https://www.niehs.nih.gov/
external/video.htm.

Availability of Meeting Materials

    A copy of the preliminary agenda, committee roster, and any 
additional information, when available, will be posted on the NTP Web 
site (https://ntp.niehs.nih.gov/ select ``Advisory Boards and 
Committees'') or may be requested in hardcopy from the NTP (see FOR 
FURTHER INFORMATION CONTACT above). Following the meeting, summary 
minutes will be prepared and made available on the NTP Web site.

Request for Comments

    Public input at this meeting is invited and time is set aside for 
the presentation of public comments on any draft technical report. Each 
organization is allowed one time slot per agenda topic. At least 7 
minutes will be allotted to each speaker, and if time permits, may be 
extended to 10 minutes. Registration for oral comments will also be 
available on-site, although time allowed for presentation by on-site 
registrants may be less than that for pre-registered speakers and will 
be determined by the number of persons who register at the meeting.
    Persons registering to make oral comments are asked, if possible, 
to send a copy of their statement to Dr. Shane (see FOR FURTHER 
INFORMATION CONTACT above) by September 13, 2005, to enable review by 
the TRR Subcommittee and NIEHS/NTP staff prior to the meeting. Written 
statements can supplement and may expand the oral presentation. If 
registering on-site and reading from written text, please bring 40 
copies of the statement for distribution to the TRR Subcommittee and 
NIEHS/NTP staff and to supplement the record. Written comments received 
in response to this notice will be posted on the NTP website. Persons 
submitting written comments should include their name, affiliation, 
mailing address, phone, fax, e-mail, and sponsoring organization (if 
any) with the document.

Background Information on the NTP Board of Scientific Counselors

    The NTP Board is a technical advisory body comprised of scientists 
from the public and private sectors who provide primary scientific 
oversight to the overall program and its centers. Specifically, the NTP 
Board advises the NTP on matters of scientific program content, both 
present and future, and conducts periodic review of the program for the 
purposes of determining and advising on the scientific merit of its 
activities and their overall scientific quality. The TRR Subcommittee 
is at standing subcommittee of the NTP Board. NTP Board members are 
selected from recognized authorities knowledgeable in fields, such as 
toxicology, pharmacology, pathology, biochemistry, epidemiology, risk 
assessment, carcinogenesis, mutagenesis, molecular biology, behavioral 
toxicology and neurotoxicology, immunotoxicology, reproductive 
toxicology or teratology, and biostatistics. The NTP strives for 
equitable geographic distribution and minority and female 
representation on the NTP Board. Its members are invited to serve 
overlapping terms of up to four years. NTP Board meetings are held 
annually or biannually.

    Dated: July 28, 2005.
Samuel H. Wilson,
Deputy Director, National Institute of Environmental Health Sciences.

Preliminary Agenda

    National Toxicology Program (NTP) Board of Scientific Counselors, 
Technical Reports Review Subcommittee Meeting, September 27-28, 2005, 
Rodbell Auditorium, Rall Building, National Institute of Environmental 
Health Sciences, 111 TW Alexander Drive, Research Triangle Park, NC.

NTP Technical Reports (TR) Scheduled for Review

 TR 524: [alpha]- and [beta]-Hydroxy acids (glycolic and 
salicylic acids, respectively) in combination with solar light (CAS 
Nos. 79-14-1 and 69-72-7, respectively)
    [cir] Used in many cosmetic formulations for the treatment of skin 
conditions including acne, ichthyosis, actnic keratosis, warts and 
psoriasis
 TR 537: Dibromoacetic acid) (CAS No. 631-64-1)
    [cir] Water disinfection by-product
 GMM 11: Dichloroacetic acid (CAS No. 79-43-6)
    [cir] Water disinfection by-product

[[Page 45406]]

 GMM 5: Bromodichloromethane (CAS No 75-27-4)
    [cir] Water disinfection by-product
 GMM 6: Sodium bromate (CAS No. 7789-38-0)
    [cir] Water disinfection by-product
 TR 534: Divinylbenzene (high purity) (CAS No. 1321-74-0)
    [cir] Used in production of vinyl polymers
 TR 538: Methyl-isobutyl ketone (CAS No. 108-10-1)
    [cir] Denaturant in rubbing alcohol, solvent for paints, used in 
industrial extraction processes, dry cleaning preparations and in 
synthetic reactions
 TR 523: Diisopropylcarbodiimide (CAS No. 693-13-0)
    [cir] Reagent for peptide synthesis, chemical intermediate and used 
in preparation of coatings
 GMM 10: Diisopropylcarbodiimide (CAS No. 693-13-0)
    [cir] Reagent for peptide synthesis, chemical intermediate and used 
in preparation of coatings
 TR 535 4-Methylmidazole (822-36-6)
    [cir] Used in manufacture of pharmaceuticals, dyes, agricultural 
chemicals and rubber

Other Topics

 Background Seizures Observed in F344/N Rats
[FR Doc. 05-15539 Filed 8-4-05; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.